Delivery Order SPE2DB22D2108-SPE2DB25FU5NE
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) with a ceiling value of $4,039.17. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, issued on August 19, 2025. The contract is non-set-aside and was competitively awarded. AmerisourceBergen's place of performance is listed as its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,023.70 on August 8, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. This order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- On July 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, executed on a firm fixed-price basis with no set-aside designation, is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging) with a ceiling value of $1,228.50. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a small-value...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5NEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded under an existing Indefinite Delivery Contract (IDC). The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is executed under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Eliquis is an anticoagulant medication used in military and veteran healthcare systems for thrombotic disease management, representing one of many specialty and brand-name medications delivered through this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/19/25 |